Gardasil gives various government agencies and their friends a pretext to get involved in a whole new area: the private lives of very young girls. Your girls.
October 23, 2009
Gardasil was promoted as the first vaccine against cancer, since it works against human papilloma virus (HPV), which is believed to instigate the growth of cancerous cells in a woman’s cervix. But since it was first hurriedly approved by the Food and Drug Administration, Gardasil has been dogged by criticism that it hasn’t been adequately tested, and by persistent reports of side effects, including deaths. So has a similar drug, Cervarix, made by GlaxoSmith-Kline.
Dr. Harper has on several occasions criticized the rush to market of both HPV drugs. But her October 2 talk at the Fourth International Public Conference on Vaccination in Reston, Va., was framed as emphasizing the benefits of Gardasil. Nevertheless, according to PRI, her presentation openly stated that, 26 million vaccinations after its debut, Gardasil will have no effect on the rate of cervical cancer in the U.S. HPV, the infection that Gardasil can prevent, is rare, usually heals itself, and testing and treatment in the U.S. are very effective in keeping cervical cancer a rare event.
Comment from Leslie -
There are 69 excellent comments to this article on American Thinker – make sure that you do read them all.